We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
Cap. Flow
-$214M
Cap. Flow %
-13.95%
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425

Top Buys

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$10.9M
2
ARNC
Arconic Corporation
ARNC
+$7.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$7.14M
4
NTES icon
NetEase
NTES
+$7.01M
5
MU icon
Micron Technology
MU
+$6.95M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$65.4M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$62.2M
3
LI icon
Li Auto
LI
+$29.4M
4
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
+$15.1M
5
BABA icon
Alibaba
BABA
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 14.1%
2 Consumer Discretionary 11.71%
3 Healthcare 9.05%
4 Industrials 8.79%
5 Financials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLNE icon
1226
Hamilton Lane
HLNE
$5.57B
– –
-3,446
Closed -$255K
HUBG icon
1227
HUB Group
HUBG
$2.92B
– –
-4,850
Closed -$204K
IART icon
1228
Integra LifeSciences
IART
$1.34B
– –
-5,164
Closed -$296K
IBP icon
1229
Installed Building Products
IBP
$6.49B
– –
-2,528
Closed -$288K
IGIC icon
1230
International General Insurance
IGIC
$1.15B
– –
-16,244
Closed -$135K
IOSP icon
1231
Innospec
IOSP
$2.28B
– –
-2,574
Closed -$264K
IOVA icon
1232
Iovance Biotherapeutics
IOVA
$2.87B
– –
-46,435
Closed -$284K
ITT icon
1233
ITT
ITT
$19.1B
– –
-4,501
Closed -$388K
IVVD icon
1234
Invivyd
IVVD
$218M
– –
-25,308
Closed -$30.4K
IWF icon
1235
PUT
iShares Russell 1000 Growth ETF
IWF
$128B
– –
-44,400
Closed -$2.71M
JBHT icon
1236
JB Hunt Transport Services
JBHT
$25.2B
– –
-1,338
Closed -$235K
JBL icon
1237
CALL
Jabil
JBL
$35.8B
– –
-11,000
Closed -$970K
JKS
1238
JinkoSolar
JKS
$891M
– –
-56,993
Closed -$2.91M
JSPR icon
1239
Jasper Therapeutics
JSPR
$23.6M
– –
-5,450
Closed -$98.6K
KBWB icon
1240
Invesco KBW Bank ETF
KBWB
$6.73B
– –
-17,990
Closed -$755K
KGC icon
1241
Kinross Gold
KGC
$32.8B
$0 ﹤0.01%
153,985
– –
KLTR icon
1242
Kaltura
KLTR
$267M
– –
-12,984
Closed -$24.9K
KOF icon
1243
Coca-Cola Femsa
KOF
$23.2B
– –
-50,579
Closed -$4.07M
KRE icon
1244
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
– –
-22,800
Closed -$1M
KRON
1245
DELISTED
Kronos Bio
KRON
– –
-23,744
Closed -$34.7K
KRUS icon
1246
Kura Sushi USA
KRUS
$593M
– –
-8,539
Closed -$562K
KWEB icon
1247
PUT
KraneShares CSI China Internet ETF
KWEB
$5.67B
– –
-10,000
Closed -$312K
LAUR icon
1248
Laureate Education
LAUR
$5.28B
– –
-11,106
Closed -$131K
LCTX icon
1249
Lineage Cell Therapeutics
LCTX
$278M
– –
-16,688
Closed -$25K
LFCR icon
1250
Lifecore Biomedical
LFCR
$190M
– –
-21,295
Closed -$80.4K
48 49
50
51 52

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.

  • Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
  • Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
  • Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
  • Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
  • Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
  • Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.